Christopher Fraser,Takashi Kei Kishimoto,Roberto A. Maldonado
申请号：
US14810442
公开号：
US20150320728A1
申请日:
2015.07.27
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+T cell help specific to an antigen.
